期刊文献+

环氧化酶-2与头颈部鳞癌关系的研究进展 被引量:2

下载PDF
导出
摘要 环氧化酶 (COX)是致炎物质前列腺素合成过程中的限速酶 ,COX - 2是环氧化酶的诱导型 ,研究显示 ,包括头颈部鳞癌 (HNSCC)在内的大多数恶性肿瘤都有COX - 2的阳性表达 ,深入研究COX - 2与头颈部鳞癌的关系 ,不仅可对HNSCC的预防提供新的途径 。
出处 《口腔医学》 CAS 2005年第1期57-59,共3页 Stomatology
  • 相关文献

参考文献25

  • 1王立峰,张伟,王吾如,王洪平,韩双廷,曲平,刘义,李茉,刘伯齐,林培中.食管癌发生发展过程中环氧合酶-2蛋白表达的研究[J].中华肿瘤杂志,2001,23(1):14-16. 被引量:32
  • 2赵明,谷志远,徐钢梅,张银凯,胡济安.成纤维细胞生长因子受体3在头颈部鳞癌中的表达及其意义[J].口腔医学,2003,23(4):211-213. 被引量:4
  • 3Peng JP, Su CY, Chang HC, et al. Expression of cyclo-oxygenase-2 is correlated with high intrammoral mlcrovessel density and low apoptotic index in human esophageal squamous cell carcinomas [ J ]. Hum Pathol, 2002,33 ( 1 ) : 100 - 104.
  • 4Gallo O, Masini E, Bianchi B, et al. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma[J]. Hum Pathol,2002,33(7) :708 - 714.
  • 5Kase S, Osaki M, Honjo S, et al. Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas [ J ]. Virchows Arch,2003,442(2) : 129 - 135.
  • 6Ranelletti FO, Almadori G, Rocca B,et al. Prognostic significance of cyclooxygenas-2 in laryngeal squamous cell carcinoma[J]. Int J Cancer, 2001,95(6) :343 - 349.
  • 7Sumitani K, Kamijo R, Toyoshima T, et al. Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production[J]. J Oral Pathol Med, 2001,30(1):41-47.
  • 8Zweifel BS, Davis TW, Omberg RL, et al. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors [ J ]. Cancer Res, 2002,62 (22) : 6706 - 6711.
  • 9Daniel TO,Liu H,Morrow JD, et al. Thromboxane A2 is a mediator of cyclooxygenase-2 dependent endothelial migration and anglonesis [ J].Cancer Res, 1999,59 ( 18 ) : 4574 - 4577.
  • 10Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis [ J ]. Neoplasia, 2001 , 3 ( 1 ) : 53 -61.

二级参考文献18

  • 1Onose H, Emoto N, Sugihara H, et al. Overexpression of fibroblast growth factor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures[J]. Eur J Endocrinol, 1999, 140(2) :163- 173.
  • 2Yamazaki K. Expression of basic fibroblast growth factor (FGF- 2) -associated with turnout proliferation in human pancreatic carcinoma[ J].Virchows Arch, 1997, 431(2):95- 101.
  • 3Wakulich C, Jackson-Boeters L, Daley TD, et al. Immunohistochemical localization of growth factors fibroblast growth factar-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma [J]. Oral Stag Oral Med Oral Pathol Oral Radiol Endod, 2002, 93 (5) : 573 - 579.
  • 4Frank R, Dellacono MD, Jeffrey Spiro MD, et al. Expression of basic fibroblast growth factor and its receptors by head and neck squamons cell carcinoma tumor and Vasscular Endothelial cells [ J ]. The American Journal of Surgery, 1997,174:540 - 544.
  • 5Van-Rhi jn BW, Lurkin 1, Radvanyi F, et al. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate[ J ]. Cancer Res, 2001, 61(4) : 1265 - 1268.
  • 6Omitz DM. FGFs heparan sulfate and FGFRs: comples interactions essential for development[J]. Bioessays, 2000, 22(2): 108- 112.
  • 7Keegan K, Johnson DE, Williams LT, et al. Isolation of an additional of the fibroblast growth factor receptor family, FGFR - 3 [ J ].Proc Natl Acad Sci USA, 1991, 88(4) : 1095 - 1099.
  • 8Cappellea D, De Oleveim C, Ricol D, et al. Frequent activating mutation of FGFR3 in human bladder and cervix carcinomas [ J ]. Nature Genet, 1999, 23(1): 18-20.
  • 9Wu R, Connolly D, Ngelangel C, et al. Somatic mutation of fibroblast growth factor receptor 3 ( FGFR3 ) are uncormnon in m of the uterine cervix[J]. Oncogene, 2000,19 (48): 5543 - 5546.
  • 10Leung HY, Gullick WJ, Lemoine NR, et al. Expression and functional activity of fibroblast growth factors and their receptor in human pancreatic cancer[J]. Int J Cancer, 1994, 59(5):667- 675.

共引文献34

同被引文献12

  • 1Giyab,黄光武,李杰恩,李佳荃,韦敏怡.血管内皮生长因子的表达及微血管密度与头颈肿瘤发生发展的关系[J].广西医科大学学报,2004,21(3):319-321. 被引量:2
  • 2Mestre J R,Machrell P J,Rivadeneira D E.Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage /monocytic cells[J].J Biol chem,2001,276(6):3977-3982.
  • 3Chan G,Boyle J O,Yang E K,et al.Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck[J].Cancer Res,1999,59(5):991-994.
  • 4Denhart B C,Guidi A J,Tognazzi K,et al.Vascular permeability factor/Vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia[J].Lab Invest,1997,77(6):659-664.
  • 5Oshima M,Murai N,Kargman S,et al.Chemoprevention of intestinal polyposis in the Apedelta 716 mouse by refecoxin,a specific cyclooxygenase-2 inhibitor[J].Cancer Res,2001,61 (4):1733-1740.
  • 6Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J].Cell,1998,93(5):705-716.
  • 7Xue Y,Feng Y,Zhu G,et al.Proliferative activity in cervical intraepithelial neoplasis and cervical carcinoma[J].Chin Med J,1999,112(4):373-375.
  • 8Volm M,Koomagi R,Mattren J.Prognostic value of vascular endothelial growth and its receptor Flt-1 in squamous cell lung cancer[J].Iht J Cancer,1997,74(1):64-69
  • 9Soslow R A,Dannenberg A J,Rush D,et al.COX-2 is expressed in human pulmonary,colonic and mammary tumor[J].Cancer,2000,89 (1):2637-2645.
  • 10Howe LR,Dannenberg AJ. A role for cyclooxgenase-2 inhibitors in the prevention and treatment of eaneer[J]. Semin Oncol, 2002, 29(3 Suppl 11):111-119.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部